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Abstract
Background and aims: There still is a lack of prospective studies on bone mineral development in patients with a
history of early onset Anorexia nervosa (AN). Therefore we assessed associations between bone mass accrual and
clinical outcomes in a former clinical sample. In addition to an expected influence of regular physical activity and
hormone replacement therapy, we explored correlations with nutritionally dependent hormones.
Methods: 3-9 years (mean 5.2 ± 1.7) after hospital discharge, we re-investigated 52 female subjects with a history
of early onset AN. By means of a standardized approach, we evaluated the general outcome of AN. Moreover,
bone mineral content (BMC) and bone mineral density (BMD) as well as lean and fat mass were measured by dual-
energy x-ray absorptiometry (DXA). In a substudy, we measured the serum concentrations of leptin and insulin-like
growth factor-I (IGF-I).
Results: The general outcome of anorexia nervosa was good in 50% of the subjects (BMI ≥ 17.5 kg/m
2,
resumption of menses). Clinical improvement was correlated with BMC and BMD accrual (c
2 = 5.62/c
2 = 6.65, p =
0.06 / p = 0.036). The duration of amenorrhea had a negative correlation with BMD (r = -.362; p < 0.01), but not
with BMC. Regular physical activity tended to show a positive effect on bone recovery, but the effect of hormone
replacement therapy was not significant. Using age-related standards, the post-discharge sample for the substudy
presented IGF-I levels below the 5
th percentile. IGF-I serum concentrations corresponded to the general outcome
of AN. By contrast, leptin serum concentrations showed great variability. They correlated with BMC and current
body composition parameters.
Conclusions: Our results from the main study indicate a certain adaptability of bone mineral accrual which is
dependent on a speedy and ongoing recovery. While leptin levels in the substudy tended to respond immediately
to current nutritional status, IGF-I serum concentrations corresponded to the individual’s age and general outcome
of AN.
Background
Anorexia nervosa (AN) is an illness with major psychia-
tric and physical components - not simply a psychiatric
condition - with a high risk of chronicity, complications,
and adverse long-term effects. During childhood and
adolescence, its specific psychopathology occurs at criti-
cal periods for bone growth and mineral accrual [1].
Mediated by nutritional deficits and hormonal
abnormalities, peak bone mass - which should be
completed around the age of 20 at least - may not be
reached. Alterations in bone microarchitecture and per-
sistent bone mineral deficiencies can follow, increasing
the risk of osteoporotic fractures [2,3]. Lean body mass
is a surrogate for muscle mass. While the nutrition-
exercise-bone mass relationship in general is said to be
complex, the enhancement of lean mass from long-term
sports participation during adolescence results in greater
bone mass accrual in healthy individuals [4]. Mechanical
forces have been described as a factor in regulating
bone modeling [5].
Deficient bone accrual is not limited to the acute
phase of illness or the most severe stage of malnutrition.
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mechanism are debated. Some authors suggest that ado-
lescent AN shows a decreased bone turnover overall, in
contrast to postmenopausal osteoporosis in which
uncoupling of bone turnover is found, i.e. markers of
increased bone resorption and decreased bone formation
[6-10].
In premenopausal women, BMD determination alone
is not adequate for assigning the labels “osteopenia” and
“osteoporosis” (as per WHO guidelines). Thus, in this
age group, labeling of changes should use terms like
“poor bone mass accumulation” or “reduced bone
mass”. Furthermore, patients themselves may be better
controls for follow-up examinations than age- and sex-
matched healthy individuals [11].
Recovery of bone mineral density (BMD) in AN is
described as a slow process [12]; it is a product of com-
plex interactions between hormonal and nutritional fac-
tors [11]. Recent data suggest that bisphosphonates are
effective in anorexic females [13]. However, at this stage,
great caution is advised and - especially in premenopau-
sal women - bisphosphonate use should be limited to
clinical trials. This also applies to estrogen therapy in
young women with AN because of the methodological
problems and application technology involved. The
results of different trials so far provide rather limited
evidence [11,14,15]. Early detection of the illness and
normalization of weight and menses are believed to be
essential [16].
Leptin plays a key part in energy homeostasis [17]. Its
serum levels correlate with body fat mass (FBM) and
body mass index (BMI) both in healthy individuals [18],
and in patients with AN [19]. In this patient group,
weight loss-associated hypoleptinemia reflects both
somatic and behavioral adaptations to starvation. The
hormone also produces anorexigenic effects in the brain.
It modulates the mesolimbic dopamine system via speci-
fic inhibitory neurons in the lateral hypothalamic area,
decreasing feeding and body weight [20,21]. Secreted by
fat cells and linking changes in body composition with
bone formation and bone resorption, the cytokine-like
hormone acts through its direct anabolic effects on
osteoblasts and also through central effects (e.g. stimula-
tion of the GH-IGF-1 axis, stimulation of beta2-adrener-
gic receptors, suppression of neuropeptide Y) [22,23].
However, we should note that both in-vitro or animal
studies and human cross-sectional studies on the role of
leptin in bone metabolism are not conclusive [24].
The IGF/IGF binding protein (IGFBP) system is
known to be an essential component in the hormonal
regulation of longitudinal growth. GH and IGF-I are
involved in bone modeling and remodeling during child-
hood and adolescence; they are important regulators of
bone homeostasis and one of the factors required to
achieve normal longitudinal bone growth and bone
mass. In adults, they are essential for bone maintenance
[5]. The IGF-I present in the systemic circulation,
synthesized by peripheral tissues, and expressed by
osteoblasts regulates bone size, shape, and composition.
Moreover, it plays a key role in adapting an individual’s
bone structure to mechanical loads during growth and
development [5,25].
In patients with AN, abnormalities in the GH/IGF-I axis
have a critical impact on the development of osteoporosis
[5]. IGF-I as a nutritionally dependent bone trophic factor
may be regarded as the major correlate of bone formation.
Its serum concentration improves with weight gain: body
mass index (BMI) is reported to show a positive correla-
tion with free IGF-I. By contrast, independent of BMI,
endogenous IGF-I, leptin, and androgen levels are sug-
gested to predict bone microarchitecture [3].
Follow-up studies on BMD in anorexic patients with
onset in childhood and adolescence are rare [26-29];
post-discharge histories in most cases are short or show
great variation [30-33]. In particular, there still is a lack
of prospective studies in this patient group. Despite the
possibility of improving BMD in the long term [34],
comparatively little is known about the effect of the gen-
eral outcome of AN on bone accrual and hormonal cor-
relations - especially with a view on former patients
with an early onset of illness. Hormonal changes which
lead to a normalization of essential bodily functions (e.g.
resumption of menses) cannot be predicted by one spe-
cific (laboratory) parameter.
Aims
The aims of our follow-up investigation were to assess
the outcome of early onset AN, and its hormonally
related effects on bone mineral parameters and their
relation to lean body mass.
Hypotheses
Because of the young age of our former patients and
early manifestation of their restrictive AN, we hypothe-
sized that bone mineral accrual would be comparatively
deficient. We also postulated that a good global out-
come and weight gain outcome would be able to coun-
teract bone mineral loss.
Expectations
We assumed a positive influence on bone mass develop-
ment due to hormonal substitution, and we furthermore
expected that moderate regular physical activity would
have a positive effect on bone mineral density [27].
Methods
We classified the extent of eating disorder symptomatol-
ogy in accordance with generally accepted clinical
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and follow-up data concerning BMD, bone mineral con-
tent (BMC), and the soft tissue composition of lean and
fat body mass (LBM, FBM) to be related to clinical
outcome.
In terms of an explorative substudy, we additionally
estimated to see some association with serum leptin
concentrations and IGF-I.
Main Study
Participants
From an original sample of 103 inpatients, we reinvesti-
gated BMD, BMC, LBM and FBM in 52 subjects (sam-
ple 1; for descriptive statistics see Table 1). Two of the
former patients had died. A statistical comparison
between participants and refusing individuals on age,
duration of follow-up, BMI, duration of amenorrhea,
BMD, BMC, LBM and FBM showed no significant dif-
ferences except in the duration of amenorrhea before
admission (5 months in participants vs. 8 months in
refusing individuals). At follow-up, 23 individuals under-
went an estrogen substitution, two of them less than
12 months.
The patients, consecutively admitted, were reexamined
by the first two authors after a post-discharge period of
5.2 years (± 1.7; range 3-9 years). All individuals met the
DSM-IV diagnostic criteria for AN (restrictive subtype)
upon admission [38]. Most of the patients had been hos-
pitalized initially for AN. Male patients were excluded
because of the small number of patients and the effects
of hormones on bone development. There were no addi-
tional inclusion or exclusion criteria.
Procedures
The study was reviewed by the appropriate institutional
review board. All patients gave informed consent prior
to their inclusion into the study. We did not measure
t h eb a s e l i n ev a l u e so ft h en u t r i t i o n a l l yd e p e n d e n t
hormones.
The initial DXA measurement (t1) was performed
within four weeks of admission. At follow-up (t2), cur-
rent body composition was compared with baseline, and
to provide comparability with previous studies of our
study group [39,40], the same reference data were used
[41-44].
At follow-up, the outcome criteria included the cur-
rent body mass index, presence or absence of menstrual
cycle, and/or bulimia nervosa (see Table 2). The general
outcome resulting from these factors (predominantly
physical parameters, but also bulimic symptoms in cases
of poor outcome) was defined according to the criteria
of Morgan and Russell, modified by Ratnasuriya [35-37].
Hormone replacement therapy was assumed if estro-
gens had been taken without interruption for at least
12 months before follow-up.
Participants who had exercised consistently for at least
9 months during the follow-up period were classified as
physically active.
Instruments
The specific eating disorder psychopathology at follow-
up was assessed using a clinical semi-structured inter-
view and the CIDI [45]. These instruments allowed the
classification of specific symptoms and their severity in
cases of persistence or manifestation of an eating dis-
order (anorexic or bulimic symptoms).
Physical examination
All participating patients underwent a physical examina-
tion to ensure an overall physical assessment.
Laboratory tests
In addition to the physical examination, we carried out a
laboratory assessment using commercially available tests
for the blood count, electrolyte balance, and pancreatic,
liver, kidney, thyroid and gonadal function.
Bone and lean body mass parameters
Dual-energy x-ray absorptiometry (DXA, LUNAR
DPX-L, Lunar Corporation, Madison, USA) was used
to perform whole body scans. These scans recorded
the total body mineral content BMC [kg], BMC pro-
jected on bone area (which is commonly defined as
BMD [g/cm
2]), lean body mass LBM [kg], and fat mass
FBM [kg]. Generally, BMD depends on the bone area
projected on a plane. Bone area adds a blurring para-
meter to bone mineral content as the primary DXA
finding.
Analysis
Statistical analysis was made using SPSS™.S t u d e n t ’s
t-test for dependent samples was used for the bone
mineral parameters. The Kruskal-Wallis test was applied
to differentiate between the three outcome groups
(good, intermediate, and poor outcome), while allowing
for the small sample size. We used the Mann-Whitney
Table 1 Sample description
Main study/sample 1 (n = 52) mean SD min max
Follow-up period (years) 5.23 1.69 3 9
Age (t1/years) 15.51 2.07 9.83 18.83
Age (t2/years) 20.78 2.72 12.80 26.70
BMI (t1) 14.74 1.88 10.42 18.67
BMI (t2) 20.13 2.79 14.26 28.14
Sub study/sample 2 (n = 39) mean SD min max
Follow-up period (years) 5.26 1.71 3 9
Age (t1/years) 15.47 2.10 9.83 18.83
Age (t2/years) 20.72 2.79 12.80 25.50
BMI (t1) 14.88 1.86 14.87 18.67
BMI (t2) 19.91 2.52 14.30 26.30
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significance level was set at: *: p < 0.05; **: p < 0.001.
The Least Significance Difference group test (LSD) for
unequal (and small) sample sizes was used to test group
range differences in the BMC z-score changes, as well as
changes in the ratio of BMC/LBM. The significance
level was set at p < 0.05. The z-scores were calculated
using a polynomial fit function based on the means and
standard deviations of the normal BMC values from
Zanchetta et al. [44].
Substudy
Participants
A subgroup of 39 participants (sample 2) also agreed to
give an additional blood sample at follow-up (for
descriptive statistics of both samples see Table 1).
Nutritionally dependent hormones
We determined the serum levels of IGF-I, and leptin by
in-house radioimmunoassays, described previously
[18,46-49]. IGF-I was measured by IGFBP-blocked assay
i nt h ep r e s e n c eo fal a r g ee x c e s so fI G F - It oi n h i b i tt h e
interference of binding proteins. The serum was always
obtained in the morning.
Analysis
Spearman’s correlation coefficients were calculated
between serum leptin levels and IGF-I, and BMD, BMC
or body composition (FBM, LBM) changes.
Results
Follow-up examinations were performed 5.2 years
(± 1.7; range 3-9 years) after discharge. The median age
of our patients at time of first examination was 15.5 years
(± 2.1; range 10-19) and 20.8 years (± 2.8; range 13-26) at
follow-up.
Mean BMI had increased from 14.7 kg/m
2 (± 1.9) to
20.1 kg/m
2 (± 2.8). Lean body mass of our patients
i n c r e a s e df r o m3 4( ±5 )t o3 9( ±4 )k gd u r i n gt h ep o s t -
discharge period.
Main study
General outcome of AN
50% (n = 26) of the post-discharge sample presented a
good general outcome (Table 2). At follow-up, 6 indivi-
duals (11.5%) suffered from anorexia or bulimia nervosa.
Duration of amenorrhea considerably differed (13-32
months; Table 2). Detailed information concerning our
former patients with a poor outcome is given on Table 3.
Physical examination
In the general physical examination, 35% of the former
patients showed dermatologic signs of AN such as acro-
cyanosis or lanugo hairs. Tanner stages were appropriate
for the individual age.
Laboratory tests
A low-T3 syndrome was found in 8 patients; 2 partici-
pants suffered from hypothyroidism; in 19 cases, a slight
increase of amylase was observed. There were no further
pathological findings.
Bone and lean body mass parameters
For the entire post-discharge sample (n = 52), all essential
body composition and bone mineralization parameters
(FBM, LBM, BMC, BMD) exhibited a considerable accrual
(Table 4). An association between the differences and gen-
eral outcome of AN was shown (Table 5). BMC z-score
changes are illustrated in Table 6.
Table 2 General outcome - sample 1 (n = 52)
Outcome n
(%)
BMI U1
(kg/m
2)
BMI U2
(kg/m
2)
amenorrhea
(months)
Good
(BMI ≥17.5; regular menstrual cycle)
26 (50.0%) 14.9 (± 1.9) 20.5 (± 2.2) 13 (± 15)
Intermediate
(BMI < 17.5 or BMI > 26; or irregular menstrual cycle/fluctuations of weight, amenorrhea)
20 (38.5%) 15.1 (± 1.9) 20.6 (± 3.0) 32 (± 27)
Poor
(BMI < 17.5; amenorrhea; bulimic symptoms)
6 (11.5%) 13.1 (± 1.9) 17.1 (± 2.6) 27 (± 16)
Table 3 Detailed information concerning the patients with a poor outcome - sample 1 (n = 52)
Individual Person Follow-up period
years
Age (t2)
(years)
BMI (t1)
(kg/m
2)
BMI (t2)
(kg/m
2)
amenorrhea
(months)
Binging/purging
A 4 19.5 14.5 16.4 14 yes
B 3 20.6 10.8 22.1 24 yes
C 4 19.5 12.8 16.6 36* no
D 4 20.3 12.5 14.3 32* no
E 3 19.5 13.9 17.0 4* no
F 7 21.7 14.4 16.5 50 yes
* Hormone resp. estrogen substitution at follow-up
Schulze et al. Child and Adolescent Psychiatry and Mental Health 2010, 4:20
http://www.capmh.com/content/4/1/20
Page 4 of 11The z-score changes in BMC values were significantly
different among the three outcome groups (good vs.
poor: p = 0.02; figure 1), whereas LBM accrual showed
no significant differences. However, the ratio of BMC to
LBM changes was significantly different between the
three outcome groups (good vs. intermediate: p <0 . 0 5 ,
good vs. poor: p < 0.02; figure 2). At follow up, the
BMC to LBM ratio had not changed in the good and
intermediate group over time, but there was a significant
deficiency in BMC accrual in the poor outcome group
(p < 0.05, Table 5).
Physical activity
A single sport or various kinds of sports (9-month
minimum) were reported by 26 (50%) of the re-investi-
gated individuals. Of these, 23 had a BMI ≥17.5 kg/m
2
at follow up. There was no significant association
between regular physical activity and weight restora-
tion (BMI ≥17.5 kg/m
2)( c
2 = 0.165; df = 1; p = 0.69).
While 16 out of 26 (61.5%) participants with a good
outcome reported that they worked out regularly, 13
of 20 (65%) individuals with an intermediate outcome
did not (c
2 = 3.185; df = 2; p = 0.20). Merging both
groups to compare them as one with the poor out-
come group, did not reveal any statistically relevant
differences.
Hormone replacement
32 patients reported taking hormone Tablets - predomi-
nantly in the form of contraceptives - for at least 12
months. Effects of hormone replacement therapy are
given in Table 7.
Correlations
The duration of amenorrhea correlated negatively with
BMD (r = –.362; p < 0.01). While regular physical activ-
ity tended to result in a gain only of BMD (– 0.063
(± 0.07) compared with 0.028 (± 0.07)), BMC showed a
positive correlation with regular work-outs. Hormone
replacement did not have a distinct influence on bone
development (Table 7). Unlike the significant group dif-
ferences in BMD baseline values (t1), the differences at
follow up did not reach statistical significance.
Substudy
General outcome of AN
The 39 participants who agreed to an additional blood
taking were classified as follows: 20 (51.3%) showed a
“good” outcome, whereas 15 (38.5%) individuals had an
“intermediate”, and 4 (10.3%) a “poor” general outcome
according to the Morgan and Russell method, modified
by Ratnasuriya [35-37].
Nutritionally dependent hormones
Serum leptin levels varied from 1.48 μg/l (the BMI of
this patient was 17.2 kg/m
2 over several years) to 43.1
μg/l (correlated with a current BMI of 22.1 kg/m
2 - this
patient had been anorectic for years and her current
Table 4 Body composition and bone parameters at first
examination (t1) and follow-up (t2) - sample 1 (n = 52)
Parameter t 1 t 2
Fat Body Mass (FBM) (%) 12 (± 7) 25 (± 8)*
Lean Body Mass (kg) 34 (± 5) 39 (± 4)*
Bone Mineral Content (kg) 2.04 (± 0.34) 2.37 (± 0.32)*
Bone Mineral Density (g/cm
2) 1.04 (± 0.08) 1.09 (± 0.07)*
*p < 0.001 (t-test for dependent samples)
Table 5 Bone mineral mass and body composition (means/SD) according to the general outcome - sample 1 (n = 52),
p-values refer to a t-test for dependent samples and indicate differences between first examination and follow-up
Outcome good
n=2 6
intermediate
n=2 0
poor
n=6
BMI (kg/m
2) 20.5 (± 2.2) 20.6 (± 3.0) 17.1 (± 2.6)
FBM (%) 27 (± 8)**
p < 0.001 (+)
25 (± 8)**
p < 0.001 (+)
19 (± 7)*
p = 0.021 (+)
Δ FBM (Mean/SD) 0.13 (± 0.10) 0.11(± 0.07) 0.12 (± 0.10)
LBM (kg) 39 (± 5)**
p < 0.001 (+)
39 (± 3)*
p = 0.001 (+)
36 (± 4)
p = 0.062 (+)
Δ LBM (Mean/SD) 4.94 (± 6.5) 3.90 (± 3.48) 4.27 (± 4.28)
BMD (g/cm
2) 1.10 (± 0.07)**
p = 0.000 (+)
1.09 (± 0.06)
p = 0.050 (+)
1.02 (± 0.08)
p = 0.125 (-)
Δ BMD (Mean/SD) 0.08 (± 0.07) 0.02 (± 0.05) -0.03 (± 0.04)
BMC (kg) 2.43 (± 0.30)**
p < 0.001 (+)
2.38 (± 0.3)**
p< 0.001 (+)
2.04 (± 0.3)
p = 0.872 (+)
Δ BMC (Mean/SD) 0.08 (± 0.07) 0.02 (± 0.05) -0.05 (± 0.04)
BMC/LBM (at follow-up) 0.062 (± 0.008)
p = 0.15
0.060 (± 0.007)
p = 0.53
0.054 (± 0.004)*
p < 0.05
Δ BMC/LBM (Mean/SD) -0.003 (± 0.008) -0.001 (± 0.008) +0.007 (± 0.004)
+ = increase, - = decrease
* p < 0.05; ** p < 0.001
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sponding weight gain of 15 kg over 2 months).
Using age-related standards (Blum, 1996) to assign the
mean values of insulin-like growth factors and its binding
proteins, IGF-I levels below the 5
th percentile were found.
Table 8 shows the analyzed bone and body composi-
tion parameters according to outcome group. The Krus-
kal-Wallis test revealed significant differences between
the groups in BMD (p = 0.03), BMC (p = 0.03) and
IGF-I (p = 0.02). In terms of trend, a better outcome
group status resulted in higher BMD, BMC and IGF-I
values.
Correlations
Correlations were found between serum leptin concen-
trations and current body composition parameters. Cor-
relations between physical status and serum and bone
parameters at follow-up are g i v e ni nT a b l e9 .S p e c i f i -
cally, there were significant correlations between leptin
and BMI, leptin and BMC, and leptin and FBM. More-
over, correlations were found between LBM and BMI,
and LBM and BMC.
Discussion
Along with assessment of the general outcome of 52
former anorexic inpatients, we tracked their bone
mineral development in a follow-up investigation. We
also investigated possible interactions between bone
mineral parameters and nutritionally dependent hor-
mones (leptin, IGF-I) in a subgroup of 39 individuals to
test the possible impact of nutritional status on bone
development.
In agreement with other follow-up studies [50-52], we
found a good general outcome after 5.3 years in half of
the post-discharge group (Table 2).
At first glance and conditionally contrary to our initial
expectations, bone mineral accrual was positive over the
entire post-discharge sample (Table 4). More explicitly
considered - and this was replicated in other studies -
clinical improvement correlated positively with both
BMC and BMD [28,53].
A good outcome of AN was associated with a small
i n c r e a s ei nB M Cz - s c o r e s( F i g u r e1 ) .T h i si so fs o m e
importance, because results of a previous study on the
body composition of 31 anorexic adolescent girls
demonstrated that BMC reflects the bone/muscle rela-
tionship better than BMD [39]. A poor outcome seems
to be associated with a tendency toward bone loss. In
spite of a possible catch-up effect associated with a good
short-term outcome [31] and a long-term absence of
clinically relevant symptoms of AN, complete normali-
zation of BMD cannot be necessarily expected [33].
Weight restoration and resumption of menses both
are known to be the most important preconditions for
bone recovery [16]. In particular, the results of a pro-
spective observational study on 34 girls with AN (aged
12-18 years) revealed that the recovery of menses is an
essential pre-condition for stabilization of BMD mea-
sures [28].
In anorexic individuals, weight gain represents a sig-
nificant and independent predictor of BMD, whereas
adipose tissue is suggested to play a substantial role in
Table 6 BMC z-score-changes and differences according
to the general outcome and in relation to each other
(Least Significance Difference Group Test) - sample 1
(n = 52)
Outcome
BMC z-core according to the
outcome
Good
M=
.399
Intermediate
M = .166
Poor
M=
.166
Good 0.32 0.02
Intermediate 0.32 0,11
Poor 0.02 0.11
Figure 1 BMC z-score changes differentiating between three
groups.
Figure 2 Differences in the ratio of bone mineral mass and
lean body mass at follow-up.
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ot a hormonal “reset”) and weight-related protective
effects on bone [54]. In our sample, fat mass revealed a
significant increase, and the duration of amenorrhea
correlated negatively with BMD, but not with BMC.
Though, weight gain alone appears not to be sufficient
to explain any increases in BMD. In a re-investigation of
a small sample of anorexic adult patients, Baker et al.
[55] showed that behavioral factors such as vomiting,
nicotine and alcohol intake also may predict a reduction
of BMD.
Amenorrhea in this patient group is thought to be an
adaptive response to an energy deficit, partially mediated
by leptin. As treatment with estrogen replacement ther-
apy does not reverse the bone loss, the administration
of recombinant leptin in order to restore LH pulsatility
and ovulatory menstrual cycle may be worth considering
prospectively [56] - but cautiously because of its anor-
exigenic effects [20,21]. On the other hand, in our sam-
ple as in several other studies, hormone replacement
therapy did not show a distinct effect on bone mineral
development [57,58].
Excessive exercise in patients with AN may be corre-
lated with increased psychopathology. It plays an impor-
tant role in the progression of the disease by
accelerating weight loss during dietary restriction. How-
ever, and also in our sample, a moderate extent of phy-
sical activity tends to result in a protection of further
bone mineral development [59,60].
An evaluation of long-term (negative) effects on BMD
in 87 women diagnosed with menstrual disorders during
adolescence revealed a restrictive eating disorder at fol-
low-up (six years after initial assessment) as the stron-
gest predictor of low BMD, whereas a BMI > 22 and
high physical activity appeared to be the most important
counter-indicators [32]. Particularly with regard to bed
rest, a pilot study on patients aged 13-21 years showed
that limitation of physical activity during hospitalization
for patients with AN is associated with suppressed bone
formation and resorption and an imbalance in bone
turnover [61]. These results agree with those on BMD
in male adolescents with AN. A follow-up study on 20
patients revealed that < 3 hours/week of physical activity
correlated strongly with osteopenia [62].
In this context, lean mass may have a functional
impact. There are rare findings that the ratio between
lean body mass and bone mineral mass accrual (BMC/
LBM) is also compromised [63]; BMC/LBM curves
always correlate linearly. Multiple regression tests have
shown little or no independent interaction of body
weight or height with those relationships [64].
In a study on 24 adolescent patients with AN, Wong
et al. found significant correlations between lean mass
and BMC/BMD, but no reduced bone mass [65],
whereas our results clearly indicate that BMC decisively
developed a deficiency in relation to LBM. (This obser-
vation is independent of z-scores or t-scores based on
any suitable reference population.)
The clinical heterogeneity of our sample is reflected in
the wide variation in serum leptin levels and presumably
also their comparatively high mean values, especially in
the poor outcome group - maybe partially caused by
Table 8 Bone mineral density, body composition and nutritional dependent hormones according to the general
outcome - sample 2 (n = 39; Means/SD)
Good
(n = 20)
intermediate
(n = 15)
poor
(n = 4)
X
2
(df = 2)
p
BMI (kg/m
2) 20,16 (± 2.10) 20,26 (± 2.10) 17.34 (± 3.37) 3.97 0.14
BMD (g/cm
2) 1,10 (± ,071) 1,08 (± ,059) 0.99 (± 0.02) 7.27 0.03*
BMC (kg) 2.37 (± 0.31) 2,35 (± 0,32) 1.92 (± 0.14) 7.28 0.03*
FBM (%) 26.85 (± 7.64) 22.76 (± 7.46) 19.53 (± 8.61) 3.64 0.16
LBM (kg) 38,28 (± 4,97) 39,16 (± 3,93) 35,37 (± 3,93) 3,47 0.18
Leptin (μg/l) 12,36 (± 12,44) 5,37 (± 2,63) 12.40 (± 20.48) 3.54 0.17
IGF-I (μg/l) 216,45 (± 80,63) 223,07 (± 71,09) 119.75 (± 37.77) 7.72 0.02*
*=p<0 . 0 5
Table 7 Effects of hormone replacement at follow-up (Mean/SD), p-values refer to a t-test for dependent samples and
indicate differences between first examination (t1) and follow-up (t2) - sample 1 (n = 52)
BMD
(g/cm
3)
BMC
(kg)
LBM
(kg)
FBM
(%)
Hormone replacement 1.10 (± 0.06)
p < 0.001 (+)
2.40 (± 0.3)
p < 0.001(+)
39 (± 5)
p < 0.001(+)
26 (± 9)
p < 0.001(+)
Without substitution 1.06 (± 0.07)
p = 0.028 (+)
2.31 (± 0.4)
p = 0.001 (+)
39 (± 4)
p < 0.001(+)
25 (± 6)
p < 0.001(+)
p-level 0.06 0.33 0.96 0.65
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Page 7 of 11frequent changes in eating behavior (Tables 3 and 8).
Current nutritional status has a possible equivalent in
individual serum glucose levels. Here, a correlation with
leptin was also found (Table 9), which may be a possible
dynamic component of glucose regulation [66,67]. Both
leptin and glucose correlated significantly with BMI and
FBM, but LBM also correlated with serum glucose
(Table 9).
Long-term and sustained weight recovery may be
necessary before significant improvements are observed
[7]. Findings in the literature for body mass index [68]
suggest that a BMI threshold value (16.4 kg/m
2)m a y
correlate with positive effects on bone formation.
Appraisals on leptin and bone development especially
in premenopausal women are rare and mostly limited to
bone turnover markers [69]. In their study on 19 anor-
exic inpatients, Heer et al. [70] associated a nutritionally
induced increase of IGF-I and leptin concentrations
(“nutritional rehabilitation”) with a possible and direct
effect on bone formation. While there was a correlation
between leptin and BMC also in our sample, we could
not demonstrate a strong association between IGF-I and
bone mineral parameters (Table 9) [71,72]. Nevertheless,
in accordance with a reported age-related decline of
IGF-I, a negative correlation between IGF-I and age was
found (Table 9) [73].
In terms of the entire group and using age-related
standards, our patients showed low serum IGF-I con-
centrations. However, there is an obvious difference
between outcome groups with poor outcome associated
with the lowest IGF-I levels and vice versa. These find-
ings agree with those of Legroux-Gerot et al., who
investigated a group of 113 women 5.7 years after eating
disorder onset [74]. Due to undernutrition, acquired GH
resistance and decreased somatostatinergic inhibition in
this patient group must be assumed [75,76].
Taken together, our results suggest a relatively direct
adaptation of leptin activity to weight gain, body compo-
sition (BMI, FBM), and subsequently to BMC changes.
Serum leptin levels significantly correlated with nutri-
tional status parameters (BMI, FBM, glucose levels),
whereas IGF-I serum concentrations did not.
Recovery status of anorexic patients does not only
refer to the actual body weight or resumption of
menses, especially in individuals who are on contracep-
tives. In the clinical context, we should carefully look on
psychopathological details (concerning eating disorder
specific core beliefs and possible comorbid conditions,
e.g. depressive or anxiety disorders), assessed by perso-
nal exploration and also by standardized instuments.
Based on a trusting relationship between patient and
therapist, especially symptoms of social anxiety and the
current individual impact of the eating disorder itself
also should be asked for.
Limitations of our study include no assessment of
bone turnover markers, the heterogenity of the group at
the time that mainly the hormones were measured, and
our comparatively small sample size. Subgroups should
have had additional explanatory power to provide a
more differentiated look at eating disorder outcome-
associated changes in bone metabolism. We have also
not collected data on nicotine or alcohol consumption.
Conclusions
Our hypotheses concerning the association between the
general outcome of AN during childhood and adoles-
cence and bone mass accrual could be confirmed. With
a view to future trends, and also in accordance with
Wentz et al., a long-term BMD catch-up is something
to hope for [34].
In our sample, bone mass accrual was clearly related to
weight gain and resumption of menses. This agrees with
the results of other studies on teenage onset anorexic
patients [27-29,34]. While hormone replacement did not
induce distinct positive effects on bone mineral develop-
ment, regular physical activity did it by trend [27]. There
was no direct association between athleticism and the
amount of weight restoration (BMI ≥ 17.5 kg/m
2).
Reduced BMD should not be seen as the decisive indi-
cator of deficient bone development due to AN, espe-
cially in the poor outcome group. The different grades
of recovery from AN, also dependent on the nutritional
state of the participants, primarily seem to have an
essential impact on the ratio of BMC to LBM. Thus, a
deficient imbalance in bone mass in relation to muscle
mass (which is a surrogate for muscle strength) during
AN, may be the cause of an increased bone fragility in
later life [77].
The interactions between the nutritional status of for-
mer anorexic patients, the re-accrual of their bone mass,
Table 9 Correlations (Spearman): body composition,
bone and serum parameters - sample 2 (n = 39)
Leptin IGF-I FBM LBM BMI BMC
age (t2) -0.30 -0.42**
BMI (body mass
index)
0.62** -0.08 0.47** 0.52**
FBM (fat body mass) 0.85** -0.12 0.68** 0.49**
LBM (lean body
mass)
0.21 0.15 0.47** 0.60**
BMC (bone mineral
content)
0.35* 0.11 0.60** 0.52**
BMD (bone mineral
density)
0.15 0.28 0.36* 0.73*
IGF-I -0.04 1.00
Glucose 0.48** -0.15 0.54** 0.35* 0.42**
*=P < 0.05
** = P < 0.01
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hormones seem to be very complex. Although the
results of a longitudinal study on 42 adolescent anorexic
females by Jagielska et al. [78] reveal an improvement in
BMC and BMD which was clearly related to the nutri-
tional status, the mechanisms underlying bone loss in
AN patients still remain unclear. Despite of the predic-
tive value of hormonal and nutritional hormones (estro-
gen, insulin-like growth factor, leptin), our detailed
knowledge about their correlations with bone mineral
development in anorexic patients still remains unsatis-
factory [79,80]. Based on this rationale, and in order to
develop a more profound understanding of these pro-
cesses and their possible influence on developing bone
microarchitecture, we should carry on measuring bone
mineral and body composition parameters parallel to
(nutritionally dependent) hormones. Further realization
is particularly supposable within the framework of inter-
disciplinary elaborated clinical studies, with an intended
impact on future therapy.
Leptin actions seem to adjust rapidly to current
changes, whereas results for IGF-I may indicate some
longer-lasting aberrance in hormonal functions due to
pathologic eating behavior. Nevertheless and propably
partly linked to the individuals amount of body fat
mass, both nutritionally dependent hormones are sug-
gested to be essential components of a preservation of
neuroendocrine control of reproductive function, also in
as u b s e to fp a t i e n t sw h om a intain menses despite low
weight [81].
The individual healing process in anorexia nervosa
requires a certain sustainability of (behavioral and psy-
chopathological) change, and not just physical stabliza-
tion. Therefore, with a view to a sustainable impact and
validity of clinical outcomes on bone mass development,
clinicians should preferably strive for an all-out and
long-lasting stabilization in their anorexic patients and
should not merely focus on weight normalization. The
key to effective treatment of early onset anorexia ner-
vosa is the early detection of disease and an evidence-
based treatment approach aiming for recovery as an
enduring and global process involving both psychologi-
cal and physiological normalization.
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